Landscapes / Companies
Cabaletta Bio not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 3 in all
Trials
5 active
7 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | Jul 2028Phase 2/3 trial completes | |||
| Next date | Jul 2028 · Phase 2/3 trial completes | ||||
| Also tested for | Pemphigus Vulgaris, Systemic Lupus Erythematosus and 13 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jan 2029Phase 1/2 trial completes | |||
| Next date | Jan 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Pemphigus Vulgaris | ||||
| Open drug page | |||||
About
- No active trial
- MuSK-CAART
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021